On the other hand, elevated circulating levels of sub clinical inflammatory markers, such as C-reactive protein (CRP) and interleukin-6 (IL-6) are reported to be significant risk indicators not only for the development of cardiovascular disease, but also for the development or progression of diabetes (9). This evidence concerns the gene CRP and cardiovascular disorder.